EMPAVELI
Google image searchProduct monograph
Active ingredient
pegcetacoplan, 1080 MG/20 ML
DIN: 02533294
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Date: 15-FEB-2023
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AJ — Complement inhibitors (ATC, ATC/DDD)
- L04AJ03 — PEGCETACOPLAN (ATC/DDD)
